Insights

The COVID recovery ASX shares to avoid

The government has put away the bazooka this time and is fighting with a peashooter. So be careful which ‘reopening’ stocks you buy.
The post The COVID recovery ASX shares to avoid appeared first on The Motley Fool Australia. –

With the Delta variant paralysing much of Australia, the market is currently very much focused on COVID-19 recovery shares.

However, multiple professionals have warned investors not to get sucked in by every pandemic recovery beneficiary.

Forces at play during the current lockdowns are very different to the investing environment during the first and second waves last year.

No big government bazooka this time

According to Ophir Funds co-founders Andrew Mitchell and Steven Ng, companies rebounded quickly during the 2021 financial year because of “mammoth” government stimulus.

“It was on a scale not seen since World War II,” they wrote in their latest letter to clients.

“It mostly covered April to September last year and was designed to help get the economy back on its feet given the nationwide lockdown in the June quarter.”

Despite this, most ASX-listed companies have been reluctant to provide guidance for the 2022 financial year. Mitchell and Ng have no doubt why this uncertainty reigns.

They wrote: “Australian governments brought the big bazooka in 2020. But so far this year it’s been more like the peashooter!

“Business support payments are much more targeted at the non-listed SME segment and are a fraction of those provided in 2020. Individual COVID disaster payments, on a per-employee basis, are closer but still trail what was provided last year.”

While there might be some pent-up consumer demand when the Delta-induced lockdowns end, the Ophir team thinks it might be overstated.

The ASX shares to avoid for COVID recovery

While Mitchell and Ng generally reckon ASX shares exposed to the ‘reopening’ economy will be rewarded by investors, they will steer clear of one type of business.

“We’ve been conscious not to be in positions that are overly reliant on government-supported demand,” they said.

Sage Capital’s latest memo to clients was along the same lines.

“With the consumer more supported than stimulated by government spending in this round of lockdowns, consumer discretionary company earnings will suffer for the first half of fiscal 2022.”

The Ophir team is also avoiding stocks that rocketed up in November last year.

“We … believe cyclically orientated businesses are unlikely to get the same boost they did last year on the initial vaccine news given earnings and economic growth momentum appears to be peaking, which sees us with a greater balance between these and more defensive type companies.”

With both the US Federal Reserve and Reserve Bank of Australia planning to reduce quantitative easing, Mitchell and Ng are “more cautious” on high-growth stocks on high valuations.

So, which ASX recovery shares do we go for?

Sage Capital is sticking to reopening beneficiaries that have the market power to set their own prices. And one sector stands out with these criteria.

“In this context, we remain long insurers with the pricing power to drive premiums higher.”

Ophir agrees with this sentiment, although Mitchell and Ng think the inflated costs will be temporary.

They wrote: “We continue to scan our portfolios to ensure the companies we invest in have some pricing power in reserve, should these higher costs become more pervasive.”

The post The COVID recovery ASX shares to avoid appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

2 ASX growth shares analysts rate as buys right now

2 ASX travel shares to consider buying

Top broker names 2 ASX dividend shares to buy

5 things to watch on the ASX 200 on Monday

2 buy-rated ASX dividend shares with 4%+ yields

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!